1-8 of 8
Daisuke Ogiya
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Role of bortezomib maintenance therapy in the anti-CD38 antibody era: Interim analysis results of a randomized Phase III study for transplant-ineligible newly diagnosed multiple myeloma (JCOG1911/B-DASH Study)

Free
Tomotaka Suzuki, Ryunosuke Machida, Yusuke Sano, Kazuyuki Shimada, Shinsuke Iida, Nobuhiko Yamauchi, Nobuhiko Nakamura, Hiroshi Handa, Yoshikazu Hori, Yasuhiro Suzuki, Daisuke Ogiya, Keisuke Kataoka, Eiji Negoro, Hiroyuki Takahashi, Junya Kuroda, Junya Makiyama, Ichiro Hanamura, Kaname Miyashita, Satoshi Ito, Hideki Uryu, Shigeru Kusumoto, Masahiro Takeuchi, Yasuhiro Harada, Takahiro Kumode, Ritsuro Suzuki, Isao Yoshida, Naoko Harada, Wataru Munakata, Hirokazu Nagai, Dai Maruyama
Journal: Blood
Blood (2025) 146 (Supplement 1): 370.
https://doi.org/10.1182/blood-2025-370
Published: 2025
Journal Articles

Identification a Novel Molecular Mechanism Underlying the Anti-CD38-Based Treatment Resistance in Multiple Myeloma Patients

Free
Sophia Adamia, Daisuke Ogiya, Evdoxia Hatjiharissi, Michael P. Chu, Zuzana Chyra, Kenneth Wen, Yu-Tzu Tai, David M. Dorfman, Teru Hideshima, Kenneth C. Anderson
Journal: Blood
Blood (2022) 140 (Supplement 1): 2081–2082.
https://doi.org/10.1182/blood-2022-169943
Published: 2022
Journal Articles

The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications

Free
Daisuke Ogiya, Jiye Liu, Hiroto Ohguchi, Keiji Kurata, Mehmet K. Samur, Yu-Tzu Tai, Sophia Adamia, Kiyoshi Ando, Teru Hideshima, Kenneth C. Anderson
Journal: Blood
Blood (2020) 136 (20): 2334–2345.
https://doi.org/10.1182/blood.2019004332
Published: 2020
Includes: Supplemental data
Journal Articles

TRAF2 Mediates Sensitivity to Immunomodulatory Drugs in the Bone Marrow Microenvironment

Free
Jiye Liu, PhD, Teru Hideshima, MD PhD, Lijie Xing, MD, Su Wang, PhD, Daisuke Ogiya, MD PhD, Mehmet K. Samur, PhD, Nikhil C. Munshi, MD, Paul G. Richardson, MD, Kenneth Wen, Yu-Tzu Tai, PhD, Yong Cang, PhD, Kenneth Anderson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31.
https://doi.org/10.1182/blood-2020-139778
Published: 2020
Journal Articles

Altered Genomic and Epigenetic Profiling of Myeloma Bone Marrow Stromal Cells Identifies Targets for Current and Future Immunotherapeutic Approaches

Free
Sophia Adamia, PhD, Daisuke Ogiya, MD PhD, Ivane Abiatari, MD, Sigitas J Verselis, PhD, Michael P. Chu, David M. Dorfman, MD PhD, Linda M. Pilarski, PhD, Teru Hideshima, MD PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3079.
https://doi.org/10.1182/blood-2019-131243
Published: 2019
Journal Articles

Aberrant RHAMM Splicing in Multiple Myeloma (MM) and Its Implications for Immunotherapy

Free
Daisuke Ogiya, MD PhD, Lisa Müller, Sigitas J Verselis, PhD, Heiner Schaal, PhD, Ivane Abiatari, MD, Ana M Stenstrom, Catherine A Nicholas, John F Daley, Michael P. Chu, David M. Dorfman, MD PhD, Linda M. Pilarski, PhD, Teru Hideshima, MD PhD, Kenneth C. Anderson, MD, Sophia Adamia, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1804.
https://doi.org/10.1182/blood-2019-131775
Published: 2019
Journal Articles

JAK-STAT3 Pathway Regulates CD38 Expression on Multiple Myeloma Cells

Free
Daisuke Ogiya, MD PhD, Jiye Liu, PhD, Hiroto Ohguchi, MD PhD, Yu-Tzu Tai, PhD, Teru Hideshima, MD PhD, Kenneth Anderson, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4440.
https://doi.org/10.1182/blood-2018-99-112425
Published: 2018
Journal Articles

NKG2D Gene Polymorphism Is Associated with Disease Control of Chronic Myeloid Leukemia By Dasatinib

Free
Ryujiro Hara, Makoto Onizuka, MD PhD, Erika Matsusita, Eri Kikkawa, Yoshihiko Nakamura, Daisuke Ogiya, Hiromichi Murayama, Ken Omachi, Yukari Shirasugi, MD PhD, Yoshiaki Ogawa, Hiroshi Kawada, Kiyoshi Ando, MDPhD
Journal: Blood
Blood (2016) 128 (22): 3091.
https://doi.org/10.1182/blood.V128.22.3091.3091
Published: 2016